Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2011
05/04/2011CN101554442B Oral blood-clearing preparation
05/04/2011CN101550152B Cefaclor compound and preparation method thereof
05/04/2011CN101550148B Refining method of Cefpodoxime proxetil compound
05/04/2011CN101550147B Cefdinir compound and preparation method thereof
05/04/2011CN101549023B Chinese medicine powder for treating beriberi
05/04/2011CN101519651B Shigella flexneri phage strain and application thereof
05/04/2011CN101497620B Purification method of penicillin and cephalosporin
05/04/2011CN101474172B Pharmacy use of ethyoxyl substituted silybin for inhibiting herpes simplex virus
05/04/2011CN101450146B Traditional Chinese medicine for treating phthisis
05/04/2011CN101433671B Medicine for treating syphilis
05/04/2011CN101391017B Medicine for treating hog cholera
05/04/2011CN101386591B Lamellarins alkaloid and preparation method and use in anti-hiv thereof
05/04/2011CN101367822B Novel dihydro arteannuin derivant, preparation method and uses as medicament
05/04/2011CN101366713B Pharmaceutic use of dandelion xylogen restraint gram-positive bacteria
05/04/2011CN101333528B SiRNA sequence for HCMV UL122 gene and applications
05/04/2011CN101284820B Amino peptidase inhibiting substance and synthetic method
05/04/2011CN101284031B Hairy holly root extract, its preparation and application
05/04/2011CN101278991B Method for testing effective ingredients of Gegen Qinlian medicine
05/04/2011CN101278986B Process for preparing compound folium isatidis injection with membrane filter technique
05/04/2011CN101272786B Lotion preparation containing pyridonecarboxylic acid derivative
05/04/2011CN101224302B Real time individuation poultry egg antibody preparation for anti Hepatitis B or C virus and preparing method and application thereof
05/04/2011CN101194973B Infusion medicament for treating impetigo
05/04/2011CN101161248B Novel anti-hepatitis B virus medicine preparing method
05/04/2011CN101070308B Isoxazoline derivative and its use
05/04/2011CN101028374B Chinese-medicinal preparation for treating liver diseases and its preparation method and use
05/03/2011US7935807 Chicken RNA polymerase I promoter and the use thereof
05/03/2011US7935805 Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
05/03/2011US7935786 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
05/03/2011US7935710 Microbicidal pyrimidine or triazine for preventing sexual HIV transmission
05/03/2011US7935705 N-alkylated rifampin
05/03/2011US7935692 Polyamine compounds are used to mobilize and harvest CD34+ cells via apheresis with and without combinations with other mobilizing factors; bind to chemokine receptors; regeneration of heart tissue
05/03/2011US7935675 Immunostimulatory nucleic acid molecules
05/03/2011US7935490 Immunodiagnostic assays using reducing agents
05/03/2011CA2499430C Chicken astrovirus type 2
05/03/2011CA2484340C 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
05/03/2011CA2476343C 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
05/03/2011CA2473026C 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
05/03/2011CA2443632C Timed pulse release composition
05/03/2011CA2440091C Prodrugs of anticancer agents employing substituted aromatic acids
05/03/2011CA2421109C Efficient method for producing compositions enriched in anthocyanins
05/03/2011CA2400394C 9-alkylamino-1-nitroacridine derivatives
05/03/2011CA2378586C Replication-competent anti-cancer vectors
05/03/2011CA2376600C Porcine circovirus recombinant poxvirus vaccine
05/03/2011CA2342966C Gene alteration in the gene for the gbeta3 subunit of the human g protein
05/03/2011CA2341503C Probiotic, lactic acid-producing bacteria and uses thereof
05/03/2011CA2328485C Humanized antibodies that recognize verotoxin ii and cell line producing same
05/03/2011CA2293805C Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment
04/2011
04/28/2011WO2011050196A2 Method for treating herpes virus infection
04/28/2011WO2011050098A2 Compositions, methods and uses for inhibition and/or treatment of influenza infection
04/28/2011WO2011049988A2 Indazoles to treat flaviviridae virus infection
04/28/2011WO2011049987A2 Azaindazoles to treat flaviviridae virus infection
04/28/2011WO2011049979A2 Injectable formulations for intra- articular or peri-articular administration
04/28/2011WO2011049914A2 Anti-hiv peptides and methods of use thereof
04/28/2011WO2011049908A2 Bismacrokyclic compounds as hepatitis c virus inhibitors
04/28/2011WO2011049825A1 Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
04/28/2011WO2011049348A2 Antiviral agents obtained from curcuma longa, having inhibitory activities against avian influenza, swine influenza, and novel influenza
04/28/2011WO2011048598A1 Compositions and methods for treating aspergillosis
04/28/2011WO2011048514A1 Derivatives of n-hydroxybenzamide for treating hiv infections
04/28/2011WO2011048350A1 Treatment using reprogrammed mature adult cells
04/28/2011WO2011048248A1 Adjuvant for vaccines, vaccines that comprise said adjuvant and uses thereof
04/28/2011WO2011048153A1 Novel acylpiperazinones and their use as pharmaceuticals
04/28/2011WO2011047814A1 Pharmaceutical compositions for treating infections with drug resistant mycobacteria
04/28/2011WO2011047531A1 Novel immunological adjuvant and vaccines comprising said adjuvant
04/28/2011WO2011047473A1 Herbal composition comprising ginger and goldenrod for the treatment of cold and flu
04/28/2011WO2011047466A1 Process and compounds for the manufacture of oseltamivir and analogs thereof, and new antiviral agents
04/28/2011WO2010151495A3 Materials and methods for treating and preventing viral infections
04/28/2011WO2010138419A3 Materials and methods for treating viral infections
04/28/2011WO2010136981A3 Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof
04/28/2011WO2010119245A3 Gamma - glutamyl transpeptidase attenuated francisella
04/28/2011WO2010032011A8 Anti-fungal therapy
04/28/2011WO2009060316A3 Hepatitis b virus-binding polypeptides and methods of use thereof
04/28/2011WO2009019616A3 Isoprekinamycin analogs and syntheses thereof
04/28/2011US20110098468 Nk1 antagonists
04/28/2011US20110098357 Vaginal suppository comprising lactic acid
04/28/2011US20110098328 Heterocyclic derivatives as modulators of ion channels
04/28/2011US20110098327 Hepatitis C Virus Inhibitors
04/28/2011US20110098294 Purine analogs
04/28/2011US20110098277 Fab I Inhibitors
04/28/2011US20110098266 Method of administering an injectable antibiotic to an animal
04/28/2011US20110098261 Triterpenoid-based compounds useful as virus inhibitors
04/28/2011US20110098253 Nitrosated Nonsteroidal Antiinflammatory Compounds, Compositions and Methods of Use
04/28/2011US20110098248 Modulators of toll-like receptors
04/28/2011US20110098239 Novel diaryl hepatonoid-based compounds and use thereof
04/28/2011US20110098238 Elucidating ligand-binding information based on protein templates
04/28/2011US20110098237 Methods for inhibiting drug degradation
04/28/2011US20110098236 Diamide inhibitors of cytochrome p450
04/28/2011US20110098215 Peptides and methods of use as therapeutics and screening agents
04/28/2011US20110098214 Lps or lipid a binding agent and novel peptide
04/28/2011US20110098212 Cytokine
04/28/2011US20110097418 Compositions and methods for treating influenza
04/28/2011US20110097412 Methods of treatment of endobronchial infections
04/28/2011US20110097395 Oral Pharmaceutical Compositions of Buprenorphine and Method of Use
04/28/2011US20110097390 Ultra-Small RNAs as Toll-Like Receptor-3 Antagonists
04/28/2011US20110097372 Devices, methods, and compositions for controlling infections
04/28/2011US20110097364 Macrocyclic lactone compounds and methods for their use
04/28/2011US20110097362 Transmucosal Administration of Aggregated Antigens
04/28/2011US20110097360 Streptococcus pneumoniae pilus antigens
04/28/2011US20110097359 Production of diphtheria toxin
04/28/2011US20110097358 RESPIRATORY SYNCYTIAL VIRUS (RSV) VIRUS-LIKE PARTICLES (VLPs)
04/28/2011US20110097357 Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cells